Search - tctmd.com

Displaying 81 - 100 of 167

Sort: Relevancy | Date

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

Presentation TVT 2019

Disparities in the Treatment of Aortic Stenosis: Race, Gender, and Referring Physician Biases

Presenter: J. Matthew Brennan

June 13, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

Presentation TVT 2019

Treatment of Severe Pulmonary Insufficiency in a Patient With Tetralogy of Fallot and Left Pulmonary Artery Stenosis With an Edwards Sapien3 Valve

Presenter: Isla McClelland

June 13, 2019

Presentation TVT 2019

A Clinical Algorithm for Diagnosing and Managing Patients With Low-Flow, Low-Gradient Aortic Stenosis

Presenter: Howard Herrmann

June 13, 2019

Presentation TVT 2019

Usefulness of Redesigned Inoue Balloon in Patients With Self-Expanding Transcatheter Valve for Aortic Stenosis: A 30-Patient Case Series

Presenter: Mike Saji

June 13, 2019

Presentation TVT 2019

Safety, Feasibility, and Acute Performance of the Leaflex™ Performer When Used Pre-TAVI in Aortic Stenosis Patients (The Leaflex™ Performer Feasibility Study)

Presenter: Axel Linke

June 13, 2019

Presentation TVT 2019

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

Meta-Analysis of 1-Year Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis

Presenter: Aaqib H Malik

June 13, 2019

News Daily News

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

Michael O'Riordan

June 12, 2019

Presentation

TAVR in Patients With End-Stage Renal Disease

June 11, 2019

News Daily News

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Yael L. Maxwell

June 11, 2019

News Daily News

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Michael O'Riordan

June 11, 2019

Presentation

Association Between TAVR for Bicuspid vs Tricuspid Aortic Stenosis and Mortality and Stroke

June 11, 2019

News Conference News EAS 2019

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

Michael O'Riordan

June 07, 2019

News Conference News SCAI 2019

TAVR Operators: Can One Do It All or Are Two Still Justified?

Yael L. Maxwell

June 04, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Caitlin E. Cox

May 24, 2019

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Shelley Wood

May 23, 2019

Advertisement

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Disparities in the Treatment of Aortic Stenosis: Race, Gender, and Referring Physician Biases

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Treatment of Severe Pulmonary Insufficiency in a Patient With Tetralogy of Fallot and Left Pulmonary Artery Stenosis With an Edwards Sapien3 Valve

A Clinical Algorithm for Diagnosing and Managing Patients With Low-Flow, Low-Gradient Aortic Stenosis

Usefulness of Redesigned Inoue Balloon in Patients With Self-Expanding Transcatheter Valve for Aortic Stenosis: A 30-Patient Case Series

Safety, Feasibility, and Acute Performance of the Leaflex™ Performer When Used Pre-TAVI in Aortic Stenosis Patients (The Leaflex™ Performer Feasibility Study)

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Meta-Analysis of 1-Year Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

TAVR in Patients With End-Stage Renal Disease

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Association Between TAVR for Bicuspid vs Tricuspid Aortic Stenosis and Mortality and Stroke

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

TAVR Operators: Can One Do It All or Are Two Still Justified?

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content